Lenvatinib/Pembrolizumab as second line treatment for advanced melanoma patients refractory to programmed death 1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors

por Ferrucci, Pier Francesco
Publicado 2023

Novel Biomarkers and Druggable Targets in Advanced Melanoma

por Ferrucci, Pier Francesco, Cocorocchio, Emilia
Publicado 2021

Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma

por Ferrucci, Pier Francesco, Pala, Laura, Conforti, Fabio, Cocorocchio, Emilia
Publicado 2021

Successful treatment with avapritinib in patient with mucosal metastatic melanoma

por Cocorocchio, Emilia, Pala, Laura, Conforti, Fabio, Guerini-Rocco, Elena, De Pas, Tommaso, Ferrucci, Pier Francesco
Publicado 2020

A New Option for the Treatment of Intrahepatic Cholangiocarcinoma: Percutaneous Hepatic Perfusion with CHEMOSAT Delivery System

por Ferrucci, Pier Francesco, Cocorocchio, Emilia, Bonomo, Guido, Varano, Gianluca Maria, Della Vigna, Paolo, Orsi, Franco
Publicado 2021

Combination of dabrafenib and radiotherapy: could skin toxicity be affected by different irradiation techniques?

por Alterio, Daniela, Marvaso, Giulia, Ferrari, Annamaria, Alessandro, Ombretta, Cocorocchio, Emilia, Ferrucci, Pier Francesco, Orecchia, Roberto, Jereczek-Fossa, Barbara Alicja
Publicado 2016

Baseline relative eosinophil count as a predictive biomarker for ipilimumab treatment in advanced melanoma

por Ferrucci, Pier Francesco, Gandini, Sara, Cocorocchio, Emilia, Pala, Laura, Baldini, Federica, Mosconi, Massimo, Antonini Cappellini, Gian Carlo, Albertazzi, Elena, Martinoli, Chiara
Publicado 2017

Cancer immunity and immunotherapy beyond COVID-19

por Bellone, Matteo, Brevi, Arianna, Bronte, Vincenzo, Dusi, Silvia, Ferrucci, Pier Francesco, Nisticò, Paola, Rosato, Antonio, Russo, Vincenzo, Sica, Antonio, Toietta, Gabriele, Colombo, Mario Paolo
Publicado 2023

Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15–16, 2020

por Bellone, Matteo, Brevi, Arianna, Bronte, Vincenzo, Dusi, Silvia, Ferrucci, Pier Francesco, Nisticò, Paola, Rosato, Antonio, Russo, Vincenzo, Sica, Antonio, Toietta, Gabriele, Colombo, Mario Paolo
Publicado 2022

ShcD Binds DOCK4, Promotes Ameboid Motility and Metastasis Dissemination, Predicting Poor Prognosis in Melanoma

por Aladowicz, Ewa, Granieri, Letizia, Marocchi, Federica, Punzi, Simona, Giardina, Giuseppina, Ferrucci, Pier Francesco, Mazzarol, Giovanni, Capra, Maria, Viale, Giuseppe, Confalonieri, Stefano, Gandini, Sara, Lotti, Fiorenza, Lanfrancone, Luisa
Publicado 2020

Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11–13 2019, Verona, Italy

por Bellone, Matteo, Bregni, Marco, Bronte, Vincenzo, Ugel, Stefano, Ferrucci, Pier Francesco, Di Nicola, Massimo, Nisticò, Paola, Zuccolotto, Gaia, Rosato, Antonio, Russo, Vincenzo, Sica, Antonio, Colombo, Mario P.
Publicado 2021

Sunny Holidays before and after Melanoma Diagnosis Are Respectively Associated with Lower Breslow Thickness and Lower Relapse Rates in Italy

por Gandini, Sara, De Vries, Esther, Tosti, Giulio, Botteri, Edoardo, Spadola, Giuseppe, Maisonneuve, Patrick, Martinoli, Chiara, Joosse, Arjen, Ferrucci, Pier Francesco, Baldini, Federica, Cocorocchio, Emilia, Pennacchioli, Elisabetta, Cataldo, Francesco, Bazolli, Barbara, Clerici, Alessandra, Barberis, Massimo, Bataille, Veronique, Testori, Alessandro
Publicado 2013

Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme

por Altomonte, Maresa, Di Giacomo, Anna Maria, Queirolo, Paola, Ascierto, Paolo Antonio, Spagnolo, Francesco, Bajetta, Emilio, Calabrò, Luana, Danielli, Riccardo, de Rosa, Francesco, Maur, Michela, Chiarion-Sileni, Vanna, Ferrucci, Pier Francesco, Giannarelli, Diana, Testori, Alessandro, Ridolfi, Ruggero, Maio, Michele
Publicado 2013

A Retrospective Analysis of Dabrafenib and/or Dabrafenib Plus Trametinib Combination in Patients with Metastatic Melanoma to Characterize Patients with Long-Term Benefit in the Ind...

por Atkinson, Victoria G., Quaglino, Pietro, Aglietta, Massimo, Del Vecchio, Michele, Depenni, Roberta, Consoli, Francesca, Bafaloukos, Dimitrios, Ferrucci, Pier Francesco, Tulyte, Skaiste, Krajsová, Ivana, Ascierto, Paolo A., Gueli, Rossana, Arance, Ana, Gogas, Helen, Banerjee, Hiya, Saliba, Teddy, de Jong, Egbert, Neyns, Bart
Publicado 2021

KEYNOTE-022 part 3: a randomized, double-blind, phase 2 study of pembrolizumab, dabrafenib, and trametinib in BRAF-mutant melanoma

por Ferrucci, Pier Francesco, Di Giacomo, Anna Maria, Del Vecchio, Michele, Atkinson, Victoria, Schmidt, Henrik, Schachter, Jacob, Queirolo, Paola, Long, Georgina V, Stephens, Rosalie, Svane, Inge Marie, Lotem, Michal, Abu-Amna, Mahmoud, Gasal, Eduard, Ghori, Razi, Diede, Scott J, Croydon, Elizabeth S, Ribas, Antoni, Ascierto, Paolo Antonio
Publicado 2020

Vitamin D Supplementation and Disease-Free Survival in Stage II Melanoma: A Randomized Placebo Controlled Trial

por Johansson, Harriet, Spadola, Giuseppe, Tosti, Giulio, Mandalà, Mario, Minisini, Alessandro M., Queirolo, Paola, Aristarco, Valentina, Baldini, Federica, Cocorocchio, Emilia, Albertazzi, Elena, Zichichi, Leonardo, Cinieri, Saverio, Jemos, Costantino, Mazzarol, Giovanni, Gnagnarella, Patrizia, Macis, Debora, Tedeschi, Ines, Salè, Emanuela Omodeo, Stucci, Luigia Stefania, Bonanni, Bernardo, Testori, Alessandro, Pennacchioli, Elisabetta, Ferrucci, Pier Francesco, Gandini, Sara
Publicado 2021

Health-related quality of life results from the phase III CheckMate 067 study

por Schadendorf, Dirk, Larkin, James, Wolchok, Jedd, Hodi, F. Stephen, Chiarion-Sileni, Vanna, Gonzalez, Rene, Rutkowski, Piotr, Grob, Jean-Jacques, Cowey, C. Lance, Lao, Christopher, Wagstaff, John, Callahan, Margaret K., Postow, Michael A., Smylie, Michael, Ferrucci, Pier Francesco, Dummer, Reinhard, Hill, Andrew, Taylor, Fiona, Sabater, Javier, Walker, Dana, Kotapati, Srividya, Abernethy, Amy, Long, Georgina V.
Publicado 2017

Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600–Mutant Unresectable or Metastatic Melanoma

por Dummer, Reinhard, Long, Georgina V., Robert, Caroline, Tawbi, Hussein A., Flaherty, Keith T., Ascierto, Paolo A., Nathan, Paul D., Rutkowski, Piotr, Leonov, Oleg, Dutriaux, Caroline, Mandalà, Mario, Lorigan, Paul, Ferrucci, Pier Francesco, Grob, Jean Jacques, Meyer, Nicolas, Gogas, Helen, Stroyakovskiy, Daniil, Arance, Ana, Brase, Jan C., Green, Steven, Haas, Tomas, Masood, Aisha, Gasal, Eduard, Ribas, Antoni, Schadendorf, Dirk
Publicado 2022

Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion

por Conforti, Fabio, Pala, Laura, Pagan, Eleonora, Bagnardi, Vincenzo, De Pas, Tommaso, Queirolo, Paola, Pennacchioli, Elisabetta, Catania, Chiara, Cocorocchio, Emilia, Ferrucci, Pier Francesco, Saponara, Maristella, Orsolini, Gianmarco, Zagami, Paola, Nicoló, Eleonora, De Marinis, Filippo, Tortora, Giampaolo, Bria, Emilio, Minucci, Saverio, Joffe, Hadine, Veronesi, Paolo, Wargo, Jennifer, Rosenthal, Rachel, Swanton, Charles, Mantovani, Alberto, Gelber, Richard D., Viale, Giuseppe, Goldhirsch, Aron, Giaccone, Giuseppe
Publicado 2021

Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study

por Queirolo, Paola, Dozin, Beatrice, Morabito, Anna, Banelli, Barbara, Piccioli, Patrizia, Fava, Cristiana, Leo, Claudio, Carosio, Roberta, Laurent, Stefania, Fontana, Vincenzo, Ferrucci, Pier Francesco, Martinoli, Chiara, Cocorocchio, Emilia, Battaglia, Angelo, Ascierto, Paolo A., Capone, Mariaelena, Simeone, Ester, De Galitiis, Federica, Pagani, Elena, Antonini Cappellini, Gian Carlo, Marchetti, Paolo, Guida, Michele, Tommasi, Stefania, Mandalà, Mario, Merelli, Barbara, Quaglino, Pietro, Fava, Paolo, Guidoboni, Massimo, Romani, Massimo, Spagnolo, Francesco, Pistillo, Maria Pia
Publicado 2017